Archives
Spartan Bioscience Launches World’s First Personal DNA Analyzer
Spartan DX(TM) device enables on-demand, real-time PCR results in 30 minutes or less.
OTTAWA, CANADA–(Marketwire - June 12, 2007) - Spartan Bioscience Inc. today announced the commercial launch of the Spartan DXTM real-time PCR (polymerase chain reaction) DNA analyzer. The Spartan DXTM provides DNA results in 30 minutes or less for 4 samples at a time. It is available at a manufacturer’s suggested retail price (MSRP) of USD $14,995. Spartan is now accepting orders for shipment during the month of July.
Highly accurate DNA testing is the “gold standard” for molecular diagnostics, but is slow and expensive since batched, mainframe-style DNA machines are designed for highly-trained scientists in high-throughput environments.
In contrast, the Spartan DXTM is designed for non-batched, on-demand DNA applications where speed and convenience are important. Applications include low-throughput research experiments and non-batched testing for infectious diseases. The Spartan DXTM has been validated against industry-leading real-time PCR machines. It is proven to be compatible with industry-standard consumables, including inexpensive reaction tubes and real-time PCR reagents and kits from leading manufacturers.
“In the same way that mainframe computers gave rise to personal computers, mainframe DNA machines are giving rise to personal DNA analyzers,” said Dr. Paul Lem, Chief Executive Officer of Spartan. “DNA is in every organism on the planet and there will be major benefits as DNA testing becomes widely available.”
About Spartan Bioscience
Founded in 2005, Spartan Bioscience Inc. is a privately-held molecular diagnostics company that develops, manufactures, and markets personal DNA analyzers for on-demand applications. The company is focusing on applications where rapid and convenient DNA testing is particularly important, such as low-throughput research experiments and non-batched testing for infectious diseases.
For media and analyst inquiries, please contact:
Shelley Mullins
Media and Analyst Relations
Spartan Bioscience Inc.
Telephone: 613-866-8803
Email: shelley.mullins@spartanbio.com
Ottawa Business Journal article – June 12, 2007
Ottawa-based Spartan Bioscience Inc. has launched its personal DNA analyzer for use where speed and convenience are important in research experiments and non-batched testing for infectious diseases.
To read the full article, click here: Article
Medagadget, The Internet Journal of Emerging Medical Technologies
If you’ve been anxiously awaiting the day that you could analyze your DNA in the comfort of your own home, then you wait is over. Plop down 15 grand and get your analyzing on!
Spartan Bioscience Inc. today announced the commercial launch of the Spartan DXTM real-time PCR (polymerase chain reaction). The Spartan DXTM provides DNA results in 30 minutes or less for 4 samples at a time. It is available at a manufacturer’s suggested retail price (MSRP) of USD $14,995. Spartan is now accepting orders for shipment during the month of July.
To read the full article, click here: Article Or copy the following into your Browser window: http://www.medgadget.com/archives/2007/06/worlds_first_personal_dna_analyzer.html
Panacis Medical Signs Manufacturing Agreement with Spartan Bioscience
OTTAWA, Panacis Medical has signed a manufacturing agreement with Spartan Bioscience to produce the first commercial units of their DNA analysis system. This agreement extends and enhances the design and development partnership between the two companies. Panacis was selected as manufacturer for its experience with “new product introduction”, reducing time and costs during the transition to high volume production. Panacis is also to support the regulatory files related to manufacturing and commercialization of Spartan products.
About Panacis Medical
With a foundation in systems engineering encompassing mechanical, low-power and wireless electronics, Panacis Medical has experience realizing product concepts. Their engineering capabilities extend across the areas of design, prototyping, and manufacturing and is a registered manufacturer of medical products with ISO certified quality management systems. To its partners, Panacis’ co-development model provides an experienced design and manufacturing team, and advice in the areas of intellectual property management, investment, and commercialization. Panacis Medical was founded 2002 and has been growing quickly since. Based in Ottawa and Montréal, with product partners around the world.
For more information, please contact:
Gregory Bridgett, Vice President of Business Operations
Panacis Medical
Telephone: +1 [613] 727-5775
Email: info@panacis.com
About Spartan Bioscience
Founded in 2005, Spartan Bioscience Inc. is a privately-held molecular diagnostics company that develops, manufactures, and markets personal DNA analyzers for on-demand applications. The company is focusing on applications where rapid and convenient DNA testing is particularly important, such as low-throughput research experiments and non-batched testing for infectious diseases.
For media and analyst inquiries, please contact:
Shelley Mullins
Media and Analyst Relations
Spartan Bioscience Inc.
Telephone: 613-866-8803
Email: shelley.mullins@spartanbio.com
